Could Reckitt spin out baby formula wing following Enfamil crisis?

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB)’s shares continue to suffer amid a series of legal challenges related to its baby formula products. The company is facing litigation and significant financial penalties due to allegations surrounding the safety and marketing of its infant nutrition products. Last week, the maker of Enfamil was ordered by a US judge to pay $60 million to a mother whose baby passed away, allegedly due to complications from consuming the formula. Though Reckitt is appealing, and s ...